F. Durupt

965 total citations · 1 hit paper
23 papers, 452 citations indexed

About

F. Durupt is a scholar working on Infectious Diseases, Epidemiology and Dermatology. According to data from OpenAlex, F. Durupt has authored 23 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Dermatology. Recurrent topics in F. Durupt's work include Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Streptococcal Infections and Treatments (4 papers). F. Durupt is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Streptococcal Infections and Treatments (4 papers). F. Durupt collaborates with scholars based in France, Morocco and Switzerland. F. Durupt's co-authors include L. Thomas, P. Sève, Yvan Jamilloux, Loïc Boussel, Sylvie Isaac, Dominique Valeyre, G. Androdias, Alain Calender, Thomas El Jammal and Mathieu Gerfaud‐Valentin and has published in prestigious journals such as The American Journal of Medicine, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

F. Durupt

17 papers receiving 427 citations

Hit Papers

Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Durupt France 8 145 121 114 104 88 23 452
Nicola Andina Switzerland 10 224 1.5× 92 0.8× 59 0.5× 260 2.5× 104 1.2× 16 921
Miguel Cordero‐Coma Spain 21 105 0.7× 142 1.2× 19 0.2× 84 0.8× 104 1.2× 67 1.3k
Ignacio J. Umbert United States 11 100 0.7× 37 0.3× 119 1.0× 22 0.2× 123 1.4× 17 372
Sumako Yoshioka Japan 12 77 0.5× 210 1.7× 34 0.3× 95 0.9× 119 1.4× 27 495
Leila Kazemi United States 7 53 0.4× 60 0.5× 41 0.4× 39 0.4× 42 0.5× 15 410
Ralf Baumann Germany 14 98 0.7× 24 0.2× 139 1.2× 76 0.7× 133 1.5× 21 547
Michelle L. McCully Canada 11 84 0.6× 31 0.3× 49 0.4× 95 0.9× 55 0.6× 21 699
Anne Theunis Belgium 13 41 0.3× 82 0.7× 195 1.7× 120 1.2× 269 3.1× 34 701
Alice Banz France 14 107 0.7× 39 0.3× 215 1.9× 150 1.4× 181 2.1× 24 767
Shinyu Izumi Japan 13 187 1.3× 121 1.0× 121 1.1× 47 0.5× 113 1.3× 26 584

Countries citing papers authored by F. Durupt

Since Specialization
Citations

This map shows the geographic impact of F. Durupt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Durupt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Durupt more than expected).

Fields of papers citing papers by F. Durupt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Durupt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Durupt. The network helps show where F. Durupt may publish in the future.

Co-authorship network of co-authors of F. Durupt

This figure shows the co-authorship network connecting the top 25 collaborators of F. Durupt. A scholar is included among the top collaborators of F. Durupt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Durupt. F. Durupt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cassier, Pierre, et al.. (2025). Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent. European Journal of Hospital Pharmacy. 33(1). 62–66.
2.
3.
Bert, Arthur A., et al.. (2021). Saddle Nose Deformity in Sarcoidosis. The American Journal of Medicine. 134(12). 1493–1494.
4.
Gerfaud‐Valentin, Mathieu, et al.. (2021). Aphthous Stomatitis in a Man with Psoriatic Arthritis. The American Journal of Medicine. 134(6). 749–750. 1 indexed citations
5.
Bergqvist, Christina, M. Beylot‐Barry, C. Ram‐Wolff, et al.. (2021). Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group. Clinical and Experimental Dermatology. 46(8). 1441–1451. 8 indexed citations
6.
Gerfaud‐Valentin, Mathieu, F. Durupt, Philippe Petiot, et al.. (2019). Eosinophilic Fasciitis and Common Variable Immunodeficiency: An Unusual Association and Literature Review. The Journal of Allergy and Clinical Immunology In Practice. 7(8). 2848–2849.e1. 1 indexed citations
7.
Villani, A., F. Aubin, Dan Lipsker, et al.. (2016). Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases. Journal of the American Academy of Dermatology. 74(6). 1153–1159. 43 indexed citations
8.
Thomas, L., Clément Journé, Isabelle Morelec, et al.. (2013). Whole‐body MRI with diffusion‐weighted sequences compared with 18 FDG PET‐CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study. Journal of the European Academy of Dermatology and Venereology. 28(2). 176–185. 35 indexed citations
9.
Durupt, F., Danijela Koppers‐Lalic, B. Balme, et al.. (2011). The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses. Cancer Gene Therapy. 19(1). 58–68. 48 indexed citations
10.
Terrier, Olivier, F. Durupt, Gaëlle Cartet, et al.. (2009). Engineering of a parainfluenza virus type 5 fusion protein (PIV-5 F): Development of an autonomous and hyperfusogenic protein by a combinational mutagenesis approach. Virus Research. 146(1-2). 115–124. 4 indexed citations
11.
Durupt, F., Michèle Bes, M.E. Reverdy, et al.. (2007). Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. British Journal of Dermatology. 157(6). 1161–1167. 57 indexed citations
12.
Durupt, F., Stéphane Dalle, Sandra Ronger, & L. Thomas. (2006). Does Erysipelas-Like Rash after Hip Replacement Exist?. Dermatology. 212(3). 216–220. 9 indexed citations
13.
Durupt, F., et al.. (2005). Hyperlactatémie symptomatique chez des patients infectés par le VIH et traités par antirétroviraux : mise au point à partir de trois nouveaux cas. Journal de Pharmacie Clinique. 24(1). 47–51.
14.
Durupt, F., et al.. (2005). Thalidomide en 2005 : mise au point et utilisation pratique. Journal de Pharmacie Clinique. 24(3). 145–157.
15.
Tristan, Anne, G. Durand, F. Durupt, et al.. (2005). Sarm: Données Épidémiologiques Récentes Et Évolution De La Résistance. Revue Francophone des Laboratoires. 2005(376). 75–79. 5 indexed citations
16.
Durupt, F., Anne Tristan, Michèle Bes, François Vandenesch, & Jérôme Étienne. (2005). Staphylococcus aureus résistant à la méticilline d'origine communautaire. Médecine et Maladies Infectieuses. 35. S38–S40. 3 indexed citations
17.
Giudice, P. Del, Véronique Blanc, F. Durupt, et al.. (2005). Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. British Journal of Dermatology. 154(1). 118–124. 46 indexed citations
18.
Durupt, F., et al.. (2004). DRESS syndrome with sulfasalazine. Journal de Pharmacie Clinique. 23(2). 115–117.
19.
Durupt, F., P. Sève, C. Roure, et al.. (2004). Liver and spleen abscesses without endocarditis due to Bartonella quintana in an immunocompetent host. European Journal of Clinical Microbiology & Infectious Diseases. 23(10). 790–791. 2 indexed citations
20.
Bouhour, Damien, et al.. (2003). [Hypersensitive reaction to abacavir or syphilitic hepatitis?].. PubMed. 32(33). 1557–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026